We are live on ! Find out more
CM

CM Management Portfolio holdings

AUM $120M
1-Year Est. Return 37.12%
This Fund
S&P 500
This Quarter Est. Return
+16.31%
1 Year Est. Return
+37.12%
3 Year Est. Return
+141.34%
5 Year Est. Return
+139.46%
10 Year Est. Return
–
AUM
$135M
AUM Growth
+$26.7M
Cap. Flow
+$13.4M
Cap. Flow %
9.95%
Top 10 Hldgs %
35.95%
Holding
101
New
21
Increased
28
Reduced
9
Closed
20

Top Buys

1
FOLD
Amicus Therapeutics
FOLD
+$5.57M
2
ALCO icon
Alico
ALCO
+$2.28M
3
ELTX icon
Elicio Therapeutics
ELTX
+$1.81M
4
EXEL icon
Exelixis
EXEL
+$1.81M
5
MRK icon
Merck
MRK
+$1.47M

Top Sells

1
ATER icon
Aterian
ATER
+$7.86M
2
AVNW icon
Aviat Networks
AVNW
+$3.95M
3
CLPT icon
ClearPoint Neuro
CLPT
+$3.34M
4
INTC icon
Intel
INTC
+$2.49M
5
GILD icon
Gilead Sciences
GILD
+$1.75M

Sector Composition

1 Healthcare 40.52%
2 Financials 13.92%
3 Technology 12.04%
4 Energy 10.02%
5 Materials 6.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DIT icon
76
AMCON Distributing
DIT
$66.4M
$340K 0.25%
4,448
– –
CRTD
77
DELISTED
Creatd Inc. Common Stock
CRTD
$323K 0.24%
75,000
-88,000
-54% -$421K
ARKOW
78
DELISTED
ARKO Corp Warrant
ARKOW
$308K 0.23%
+150,000
New +$265K
TEVA icon
79
Teva Pharmaceuticals
TEVA
$37.3B
$289K 0.21%
+25,000
New +$287K
PTPI
80
DELISTED
Petros Pharmaceuticals
PTPI
$168K 0.12%
180
– –
CRTDW
81
DELISTED
Creatd Inc. Warrant
CRTDW
$18K 0.01%
+9,042
New +$18.7K
AMRX icon
82
Amneal Pharmaceuticals
AMRX
$5.7B
– –
-125,000
Closed -$571K
AMSC icon
83
American Superconductor
AMSC
$1.6B
– –
-19,589
Closed -$459K
AVNW icon
84
Aviat Networks
AVNW
$268M
– –
-231,536
Closed -$3.95M
CASY icon
85
Casey's General Stores
CASY
$31.8B
– –
-1,000
Closed -$179K
CATY icon
86
Cathay General Bancorp
CATY
$4.2B
– –
-15,000
Closed -$483K
CLPT icon
87
ClearPoint Neuro
CLPT
$455M
– –
-210,000
Closed -$3.34M
EOLS icon
88
Evolus
EOLS
$378M
– –
-46,620
Closed -$157K
GILD icon
89
Gilead Sciences
GILD
$167B
– –
-30,000
Closed -$1.75M
HII icon
90
Huntington Ingalls Industries
HII
$10.6B
– –
-1,000
Closed -$170K
INTC icon
91
Intel
INTC
$477B
– –
-50,000
Closed -$2.49M
LTRN icon
92
Lantern Pharma
LTRN
$36.6M
– –
-10,000
Closed -$193K
LUMN icon
93
Lumen
LUMN
$6.46B
– –
-30,000
Closed -$293K
FLNA
94
Filana Therapeutics
FLNA
$51.2M
– –
-175,000
Closed -$1.19M
SPG icon
95
Simon Property Group
SPG
$74.1B
– –
-5,000
Closed -$426K
SVC
96
Service Properties Trust
SVC
$1.11B
– –
-10,000
Closed -$575K
WBD icon
97
Warner Bros
WBD
$67.3B
– –
-30,000
Closed -$903K
ZDGE icon
98
Zedge
ZDGE
$39.6M
– –
-40,000
Closed -$242K
ITCI
99
DELISTED
Intra-Cellular Therapies Inc.
ITCI
– –
-25,000
Closed -$795K
TBNK
100
DELISTED
Territorial Bancorp Inc.
TBNK
– –
-11,132
Closed -$268K
1 2 3
4
5

Similar funds

AA
Ahara Advisors Jersey City, New Jersey $120M AUM
CC
Commons Capital Needham, Massachusetts $120M AUM 31.45% 1-Year Est. Return
DG
Dala Group Hoffman Estates, Illinois $120M AUM
ACM
AIHC Capital Management Central $120M AUM
WAG
Windsor Advisory Group Columbus, Ohio $120M AUM 4.29% 1-Year Est. Return
YMRC
Yorktown Management & Research Company Forest, Virginia $120M AUM 52.72% 1-Year Est. Return
IW
Integrated Wealthcare Durham, North Carolina $120M AUM
BCWM
Ball & Co Wealth Management Franklin, Tennessee $120M AUM 21.28% 1-Year Est. Return

CM Management's Q1 2021 Portfolio in Review

As of Q1 2021, CM Management held 101 positions worth $135M, up 25% from $108M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

CM Management deployed $13.4M of net new capital in Q1 2021, opening 21 new positions and adding to 28 existing holdings. Its largest new stake was Elicio Therapeutics: 9,375 shares worth $1.69M.

By sector, the portfolio is most concentrated in Healthcare at 41% of assets, up from 37% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Aterian, an estimated $7.86M trimmed.

  • CM Management's largest Q1 2021 buy was Elicio Therapeutics: 9,375 shares worth $1.69M.
  • CM Management added most to Amicus Therapeutics in Q1 2021, an estimated $5.57M increase.
  • CM Management's biggest Q1 2021 reduction was Aterian, cutting an estimated $7.86M.
  • CM Management fully exited Aviat Networks in Q1 2021, selling an estimated $3.95M.
  • CM Management's ten largest holdings make up 36% of its $135M portfolio in Q1 2021.
  • CM Management opened 21 new positions and closed 20 in Q1 2021.
  • CM Management's portfolio value rose 25% quarter-over-quarter to $135M.

Based on CM Management's 13F filing for Q1 2021, filed 12 May 2021.